T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Fidelity National Information Services
FIS
|
+$3.15B |
| 2 |
NextEra Energy, Inc.
NEE
|
+$1.96B |
| 3 |
Global Payments
GPN
|
+$1.95B |
| 4 |
Salesforce
CRM
|
+$1.48B |
| 5 |
Boeing
BA
|
+$1.47B |
Top Sells
| 1 |
WP
Worldpay, Inc.
WP
|
+$3.23B |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$1.76B |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$1.49B |
| 4 |
Bank of America
BAC
|
+$1.45B |
| 5 |
Pfizer
PFE
|
+$1.22B |
Sector Composition
| 1 | Technology | 19.69% |
| 2 | Healthcare | 15.84% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 13.43% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Rocket Pharmaceuticals
RCKT
$341M
| $16.5M | ﹤0.01% |
1,416,945
+243,999
| +21% | +$2.84M |
|
1202
PTC
PTC
$24.6B
| $16.5M | ﹤0.01% |
241,880
-63,048
| -21% | -$4.3M |
|
1203
Integer Holdings
ITGR
$3.55B
| $16.4M | ﹤0.01% |
216,713
+1,954
| +0.9% | +$148K |
|
1204
PVH
PVH
$3.9B
| $16.4M | ﹤0.01% |
185,384
-812
| -0.4% | -$71.6K |
|
|
CDK
1205
DELISTED
CDK Global, Inc.
CDK
| $16.3M | ﹤0.01% |
338,556
-62,008
| -15% | -$2.98M |
|
1206
CytomX Therapeutics
CTMX
$330M
| $16.3M | ﹤0.01% |
2,205,101
-595,771
| -21% | -$4.4M |
|
1207
Aramark
ARMK
$10.1B
| $16.2M | ﹤0.01% |
515,370
-7,541,500
| -94% | -$237M |
|
1208
Zymeworks
ZYME
$1.19B
| $16.2M | ﹤0.01% |
652,016
+348,595
| +115% | +$8.65M |
|
|
LL
1209
DELISTED
LL Flooring Holdings, Inc.
LL
| $16.2M | ﹤0.01% |
1,637,468
-1,138,812
| -41% | -$11.2M |
|
|
DCPH
1210
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $16.1M | ﹤0.01% |
+475,504
| New | +$16.1M |
|
|
HZN
1211
DELISTED
Horizon Global Corporation
HZN
| $16.1M | ﹤0.01% |
4,222,490
+734,562
| +21% | +$2.81M |
|
|
TECX
1212
Tectonic Therapeutic, Inc. Common Stock
TECX
$332M
| $16.1M | ﹤0.01% |
95,039
+27,686
| +41% | +$4.69M |
|
1213
Kimco Realty
KIM
$15.2B
| $16M | ﹤0.01% |
767,219
-2,108,943
| -73% | -$44M |
|
|
AVLR
1214
DELISTED
Avalara, Inc.
AVLR
| $16M | ﹤0.01% |
237,178
-171
| -0.1% | -$11.5K |
|
1215
Sabre
SABR
$738M
| $15.8M | ﹤0.01% |
705,481
+13,293
| +2% | +$298K |
|
1216
Pacira BioSciences
PCRX
$1.22B
| $15.6M | ﹤0.01% |
409,320
+4,947
| +1% | +$188K |
|
1217
Zai Lab
ZLAB
$3.61B
| $15.5M | ﹤0.01% |
477,921
+46,588
| +11% | +$1.51M |
|
1218
Red Rock Resorts
RRR
$3.65B
| $15.4M | ﹤0.01% |
759,948
+793
| +0.1% | +$16.1K |
|
1219
Stitch Fix
SFIX
$714M
| $15.4M | ﹤0.01% |
800,443
-137,799
| -15% | -$2.65M |
|
|
AYX
1220
DELISTED
Alteryx, Inc.
AYX
| $15.4M | ﹤0.01% |
143,146
-56,510
| -28% | -$6.07M |
|
|
AIV
1221
Aimco
AIV
$1.07B
| $15.3M | ﹤0.01% |
2,204,403
-97,408
| -4% | -$677K |
|
1222
Axalta
AXTA
$6.75B
| $15.2M | ﹤0.01% |
505,443
-4,098
| -0.8% | -$124K |
|
1223
F5
FFIV
$18.5B
| $15.2M | ﹤0.01% |
108,189
-4,207
| -4% | -$591K |
|
1224
Blackstone
BX
$142B
| $15.2M | ﹤0.01% |
+310,600
| New | +$15.2M |
|
1225
FS Bancorp
FSBW
$315M
| $15.2M | ﹤0.01% |
577,206
+50,884
| +10% | +$1.34M |
|